Related Experiment Videos
The effect of cephalothin prophylaxis on postoperative ventriculoperitoneal shunt infections
Insights
Prophylactic cephalothin did not significantly reduce postoperative infection rates after ventriculoperitoneal (VP) shunt insertion in children. Further large-scale trials are needed to confirm the efficacy of antibiotic prophylaxis for preventing VP shunt infections.
Area of Science:
- Pediatric Neurosurgery
- Infectious Disease Prevention
Background:
- Postoperative infection is a significant complication following ventriculoperitoneal (VP) shunt placement in pediatric hydrocephalus patients.
- Preventing shunt infection is crucial for improving patient outcomes and reducing healthcare costs.
Purpose of the Study:
- To evaluate the efficacy of prophylactic cephalothin in preventing postoperative infections in children undergoing elective VP shunt insertion.
Main Methods:
- A randomized, double-blind, placebo-controlled study involving 63 pediatric patients.
- Patients received either four doses of cephalothin (25 mg/kg) or a multivitamin placebo.
- Infection rates were compared between the treatment and placebo groups.
Main Results:
- The infection rate was 6% in the cephalothin group and 10% in the placebo group.
- This difference was not statistically significant, potentially due to the small sample size.
- A trend towards lower infection in the treatment group suggests potential clinical significance.
Conclusions:
- The study did not demonstrate a statistically significant benefit of prophylactic cephalothin in preventing postoperative VP shunt infections.
- A larger, multicenter trial is recommended to definitively assess the efficacy of antibiotic prophylaxis for VP shunt infections.
Abstract:
Postoperative infection is an important complication after insertion of a ventriculoperitoneal (VP) shunt in children with hydrocephalus. A randomized double-blind placebo-controlled study was performed to determine the efficacy of cephalothin in preventing postoperative shunt infection. Sixty-three children who presented for elective VP shunt insertion between January 1982 and December 1985 and who did not have a history of shunt infections were randomly assigned to receive four doses of prophylactic cephalothin, 25 mg/kg (32 patients), or of a multivitamin placebo (31 patients). Postoperative infection developed in 6% of the treatment group, compared with 10% of the placebo group, a difference that was not statistically significant, although a clinical significance may have been masked by the small sample size. A large multicentre trial is needed to determine the efficacy of antibiotic prophylaxis in reducing the incidence of postoperative VP shunt infections.